Skip to Main Content

Paper Details

Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the US.
JAMA Netw Open
21
2022
CD4, CD4 cell, COVID-19, COVID-19 breakthrough illness, Corona-Infectious-Virus, HIV, HIV infection, PWH, PWoH, SARS, SARS-CoV-2, cancer, immune suppression, patients, people
Author NameAffiliation
Michael A HorbergKaiser Permanente Mid-Atlantic States, Mid-Atlantic Permanente Research Institute
Amy C JusticeVA Connecticut Healthcare System
Amy C JusticeYale School of Public Health
Amy C JusticeYale School of Medicine
Michael J SilverbergKaiser Permanente Northern California
Kelly A GeboJohns Hopkins Bloomberg School of Public Health
Kelly A GeboJohns Hopkins School of Medicine
Vincent C MarconiEmory University School of Medicine
Vincent C MarconiAtlanta Veterans Affairs Medical Center
Vincent C MarconiRollins School of Public Health
Carolyn WilliamsDivision of AIDS at National Institute of Allergy and Infectious Diseases, National Institute of Health
Keri N AlthoffJohns Hopkins Bloomberg School of Public Health
  • 1 - 12

Datasets

Release 1.2